Convalife Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 67

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 12

Convalife Pharmaceuticals General Information

Description

Researcher and developer of innovative drugs focused on oncology treatments. The company focuses on antibody biopharmaceuticals and small molecule drug in tumor disease field, aiming to provide cancer patients with treatment options.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 26, Lane 1000, Zhangheng Road
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • No. 26, Lane 1000, Zhangheng Road
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021

Convalife Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Convalife Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. IPO 31-Aug-2025 Announced Generating Revenue
8. Later Stage VC (Series C2) 30-Jul-2025 Completed Generating Revenue
7. Secondary Transaction - Private 19-Jun-2025 Completed Generating Revenue
6. Secondary Transaction - Private 08-Nov-2024 Completed Generating Revenue
5. Later Stage VC (Series C) 04-Jan-2024 Completed Clinical Trials - General
4. Later Stage VC (Series B) 04-Jan-2023 Completed Clinical Trials - General
3. Later Stage VC (Series A) 09-Apr-2021 Completed Clinical Trials - General
2. Later Stage VC 06-Aug-2020 $2M $3.49M Completed Clinical Trials - General
1. Early Stage VC 22-Dec-2019 $1.49M $1.49M Completed Clinical Trials - General
To view Convalife Pharmaceuticals’s complete valuation and funding history, request access »

Convalife Pharmaceuticals Patents

Convalife Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026228753-A1 Pyrimidoindole compound, and composition comprising same and use thereof Pending 30-Apr-2025
WO-2026228751-A1 Polysubstituted pyridine derivative, and preparation method therefor and use thereof Pending 29-Apr-2025
WO-2026228599-A1 1,2,3,6-tetrahydropyridine-4-carboxylic acid derivative, and composition and use thereof Pending 28-Apr-2025
WO-2026218559-A1 Diphenyl ether derivative, intermediate thereof, and use thereof Pending 18-Apr-2025
WO-2026219178-A1 Pharmaceutical composition and use thereof Pending 14-Apr-2025
To view Convalife Pharmaceuticals’s complete patent history, request access »

Convalife Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Convalife Pharmaceuticals Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Optics Valley Financial Holdings Group Corporation Minority
Wuhan High Tech Medical Instrument Park Corporation Minority
Chengrong Investment Growth/Expansion Minority
Veken Holding Group Corporation Minority
Vista Investment Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Convalife Pharmaceuticals FAQs

  • When was Convalife Pharmaceuticals founded?

    Convalife Pharmaceuticals was founded in 2015.

  • Where is Convalife Pharmaceuticals headquartered?

    Convalife Pharmaceuticals is headquartered in Shanghai, China.

  • What is the size of Convalife Pharmaceuticals?

    Convalife Pharmaceuticals has 67 total employees.

  • What industry is Convalife Pharmaceuticals in?

    Convalife Pharmaceuticals’s primary industry is Drug Delivery.

  • Is Convalife Pharmaceuticals a private or public company?

    Convalife Pharmaceuticals is a Private company.

  • What is Convalife Pharmaceuticals’s current revenue?

    The current revenue for Convalife Pharmaceuticals is .

  • How much funding has Convalife Pharmaceuticals raised over time?

    Convalife Pharmaceuticals has raised $59.8M.

  • Who are Convalife Pharmaceuticals’s investors?

    Optics Valley Financial Holdings Group, Wuhan High Tech Medical Instrument Park, Chengrong Investment, Veken Holding Group, and Vista Investment are 5 of 12 investors who have invested in Convalife Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process